Mera Pharmaceuticals Inc (MRPI)
0.00
USD |
OTCM |
May 21, 16:00
Mera Pharmaceuticals Max Drawdown (5Y): 100.00% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 100.00% |
| March 31, 2024 | 100.00% |
| February 29, 2024 | 100.00% |
| January 31, 2024 | 100.00% |
| December 31, 2023 | 100.00% |
| November 30, 2023 | 99.64% |
| October 31, 2023 | 99.64% |
| September 30, 2023 | 99.64% |
| August 31, 2023 | 99.64% |
| July 31, 2023 | 99.64% |
| June 30, 2023 | 99.64% |
| May 31, 2023 | 99.64% |
| April 30, 2023 | 99.64% |
| March 31, 2023 | 99.64% |
| February 28, 2023 | 99.64% |
| January 31, 2023 | 99.64% |
| December 31, 2022 | 99.64% |
| November 30, 2022 | 99.64% |
| October 31, 2022 | 99.64% |
| September 30, 2022 | 99.64% |
| August 31, 2022 | 99.64% |
| July 31, 2022 | 99.29% |
| June 30, 2022 | 99.29% |
| May 31, 2022 | 99.29% |
| April 30, 2022 | 99.29% |
| Date | Value |
|---|---|
| March 31, 2022 | 99.29% |
| February 28, 2022 | 99.29% |
| January 31, 2022 | 99.29% |
| December 31, 2021 | 99.29% |
| November 30, 2021 | 99.29% |
| October 31, 2021 | 98.21% |
| September 30, 2021 | 98.21% |
| August 31, 2021 | 94.74% |
| July 31, 2021 | 94.74% |
| June 30, 2021 | 94.74% |
| May 31, 2021 | 94.74% |
| April 30, 2021 | 94.74% |
| March 31, 2021 | 94.74% |
| February 28, 2021 | 94.74% |
| January 31, 2021 | 95.92% |
| December 31, 2020 | 97.96% |
| November 30, 2020 | 97.96% |
| October 31, 2020 | 97.96% |
| September 30, 2020 | 97.96% |
| August 31, 2020 | 97.96% |
| July 31, 2020 | 97.96% |
| June 30, 2020 | 97.96% |
| May 31, 2020 | 97.96% |
| April 30, 2020 | 97.96% |
| March 31, 2020 | 97.96% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
94.74%
Minimum
Feb 2021
100.00%
Maximum
Dec 2023
98.38%
Average
98.75%
Median
Max Drawdown (5Y) Benchmarks
| CEL-SCI Corp | 96.13% |
| AIM ImmunoTech Inc | 99.76% |
| IGC Pharma Inc | 97.77% |
| NovaBay Pharmaceuticals Inc | 99.91% |
| Protalix BioTherapeutics Inc | 94.35% |